+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Biotechnology Instrumentation - Global Market Trajectory & Analytics

  • ID: 338888
  • Report
  • April 2021
  • Region: Global
  • 233 Pages
  • Global Industry Analysts, Inc
Global Biotechnology Instrumentation Market to Reach $62.4 Billion by 2027

Amid the COVID-19 crisis, the global market for Biotechnology Instrumentation estimated at US$42.5 Billion in the year 2020, is projected to reach a revised size of US$62.4 Billion by 2027, growing at a CAGR of 5.6% over the analysis period 2020-2027. Immunoassay Systems, one of the segments analyzed in the report, is projected to record a 4.5% CAGR and reach US$21.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the DNA Sequencing Systems segment is readjusted to a revised 8.1% CAGR for the next 7-year period.

The U.S. Market is Estimated at $12.5 Billion, While China is Forecast to Grow at 5.3% CAGR

The Biotechnology Instrumentation market in the U.S. is estimated at US$12.5 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$11 Billion by the year 2027 trailing a CAGR of 5.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.2% and 4.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.

Mass Spectrometry Segment to Record 6.8% CAGR

In the global Mass Spectrometry segment, USA, Canada, Japan, China and Europe will drive the 6.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$3.9 Billion in the year 2020 will reach a projected size of US$6.3 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$7.2 Billion by the year 2027.

Select Competitors (Total 131 Featured):
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Beckman Coulter Inc.
  • Bio-Rad Laboratories Inc.
  • Bruker Corporation
  • GE HealthCare (UK)
  • Gilson Inc.
  • Harvard Bioscience Inc.
  • Hitachi High-Technologies Corp.
  • Illumina Inc.
  • Lonza Group AG
  • PerkinElmer Inc.
  • Roche Diagnostics
  • Shimadzu Corp.
  • Siemens Healthineers
  • Thermo Fischer Scientific Inc.
  • Waters Corp.)
Note: Product cover images may vary from those shown
I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Biotechnology Tools - Driven by Advancements
  • Recent Market Activity
  • Global Market Analysis
  • Factors Sustaining Market Growth
  • Factors Restraining Growth
  • Improving Economy Signals Market Growth Opportunities
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
  • Abbott Laboratories (USA)
  • Agilent Technologies, Inc. (USA)
  • Beckman Coulter, Inc. (USA)
  • Bio-Rad Laboratories, Inc. (USA)
  • Bruker Corporation (USA)
  • GE HealthCare (UK)
  • Gilson, Inc. (USA)
  • Harvard Bioscience, Inc. (USA)
  • Hitachi High-Technologies Corp. (Japan)
  • Illumina, Inc. (USA)
  • Lonza Group AG (Switzerland)
  • PerkinElmer, Inc. (USA)
  • Roche Diagnostics (Switzerland)
  • Shimadzu Corp. (Japan)
  • Siemens Healthineers (USA)
  • Thermo Fisher Scientific, Inc. (USA)
  • Waters Corp. (USA)
3. MARKET TRENDS & DRIVERS
  • DNA Sequencing
  • Future Diagnostic Applications of DNA Sequencing
  • Next-Generation Sequencing Technologies Drive the Momentum
  • Liquid Chromatography
  • Growth in New Application Markets
  • HPLC Offers Significant Growth Opportunities
  • Innovative HPLC Products Inject New Growth
  • Ultra-High Pressure Liquid Chromatography
  • MS Systems with UHPLC
  • Advancements in HPLC Columns
  • Electrophoresis Systems
  • Capillary Gel Electrophoresis - Gains Prominence
  • Product Innovations Sustain Sales
  • Immunoassay Instruments
  • Growth Opportunities and Areas
  • Automated Multiplexing Platforms Present Growth Opportunities
  • Radioimmunoassay Systems Lose Ground
  • Chemiluminescence Immunoassays Gain Demand
  • Mass Spectrometry
  • Technological Developments and Expanding End-Use Applications to Bolster Growth
  • A Review for Select MS Technologies
  • Portability: A Major Driving Force for MS Systems Market
  • Nanotube Coating to Enable Miniaturization in Mass Spectrometers
  • High Prices of MS Systems Hold Down Sales Growth
  • Purpose-Built Mass Spectrometers to Transform Personalized Medicine
  • Lack of SuiTable Software and Diversity of MS Systems - A Major Challenge
  • Smaller Clinical Laboratories Continue to Shy Away from Mass Spectrometers
  • Microarrays
  • Protein Biochips - Set for Robust Expansion
  • Lab-on-a-Chip: Fusion of Nanotechnology & Genetic Engineering
  • Advancements in Biochip Technology
  • Biochip Technology Boosts Personalized Medicine
  • Biochip Technology Spreads beyond Pharma Industry
  • Data on Specificity of Effect Drives Use of Microarrays in Cosmetics and Personal Healthcare
  • Laboratory Automation
  • Technology Sets the Momentum for Microplate Reader Market
  • Growing Options in Multimode Microplate Readers
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Current & Future Analysis for Biotechnology Instrumentation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 2: World Historic Review for Biotechnology Instrumentation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 3: World 15-Year Perspective for Biotechnology Instrumentation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
  • Table 4: World Current & Future Analysis for Immunoassay Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 5: World Historic Review for Immunoassay Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 6: World 15-Year Perspective for Immunoassay Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 7: World Current & Future Analysis for DNA Sequencing Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 8: World Historic Review for DNA Sequencing Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 9: World 15-Year Perspective for DNA Sequencing Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 10: World Current & Future Analysis for Mass Spectrometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 11: World Historic Review for Mass Spectrometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 12: World 15-Year Perspective for Mass Spectrometry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 13: World Current & Future Analysis for MicroArrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 14: World Historic Review for MicroArrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 15: World 15-Year Perspective for MicroArrays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 16: World Current & Future Analysis for Liquid Chromatography Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 17: World Historic Review for Liquid Chromatography Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 18: World 15-Year Perspective for Liquid Chromatography Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 19: World Current & Future Analysis for Laboratory Automation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 20: World Historic Review for Laboratory Automation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 21: World 15-Year Perspective for Laboratory Automation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 22: World Current & Future Analysis for Electrophoresis Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 23: World Historic Review for Electrophoresis Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 24: World 15-Year Perspective for Electrophoresis Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 25: World Current & Future Analysis for Other Product Segments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 26: World Historic Review for Other Product Segments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 27: World 15-Year Perspective for Other Product Segments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
III. MARKET ANALYSIS
  • UNITED STATES
  • Table 28: USA Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 29: USA Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 30: USA 15-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2012, 2020 & 2027
  • CANADA
  • Table 31: Canada Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 32: Canada Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 33: Canada 15-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2012, 2020 & 2027
  • JAPAN
  • Table 34: Japan Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 35: Japan Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 36: Japan 15-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2012, 2020 & 2027
  • CHINA
  • Table 37: China Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 38: China Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 39: China 15-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2012, 2020 & 2027
  • EUROPE
  • Table 40: Europe Current & Future Analysis for Biotechnology Instrumentation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 41: Europe Historic Review for Biotechnology Instrumentation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 42: Europe 15-Year Perspective for Biotechnology Instrumentation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
  • Table 43: Europe Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 44: Europe Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 45: Europe 15-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2012, 2020 & 2027
  • FRANCE
  • Table 46: France Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 47: France Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 48: France 15-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2012, 2020 & 2027
  • GERMANY
  • Table 49: Germany Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 50: Germany Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 51: Germany 15-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2012, 2020 & 2027
  • ITALY
  • Table 52: Italy Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 53: Italy Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 54: Italy 15-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
  • Table 55: UK Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 56: UK Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 57: UK 15-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2012, 2020 & 2027
  • REST OF EUROPE
  • Table 58: Rest of Europe Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 59: Rest of Europe Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 60: Rest of Europe 15-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
  • Table 61: Asia-Pacific Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 62: Asia-Pacific Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 63: Asia-Pacific 15-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2012, 2020 & 2027
  • REST OF WORLD
  • Table 64: Rest of World Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 65: Rest of World Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 66: Rest of World 15-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2012, 2020 & 2027
IV. COMPETITION
  • Total Companies Profiled: 131
Note: Product cover images may vary from those shown
Adroll
adroll